Premium
Response to Commentary on “The neuroinvasive potential of SARS‐CoV‐2 may play a role in the respiratory failure of COVID‐19 patients”
Author(s) -
Li YanChao,
Bai WanZhu,
Hashikawa Tsutomu
Publication year - 2020
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.25824
Subject(s) - coronavirus , covid-19 , pandemic , medicine , respiratory failure , respiratory system , causation , severe acute respiratory syndrome coronavirus , disease , severe acute respiratory syndrome , intensive care medicine , virology , betacoronavirus , neuroscience , infectious disease (medical specialty) , pathology , psychology , outbreak , political science , law
In a recent review, we have suggested a neuroinvasive potential of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and its possible role in the causation of acute respiratory failure of coronavirus disease 2019 (COVID‐19) patients ( J Med Viol doi: 10.1002/jmv.25728), based upon the clinical and experimental data available on the past SARS‐CoV‐1 and the recent SARS‐CoV‐2 pandemic. In this article, we provide new evidence recently reported regarding the neurotropic potential of SARS‐CoV‐2 and respond to several comments on our previously published article. In addition, we also discuss the peculiar manifestations of respiratory failure in COVID‐19 patients and the possible involvement of nervous system.